These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29431526)

  • 21. Statins and Elderly: From Clinical Trials to Daily Practice.
    Verdoia M; Galasso G; Filardi PP; De Luca G
    Curr Vasc Pharmacol; 2019; 17(3):233-238. PubMed ID: 29956633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins in liver disease: a molehill, an iceberg, or neither?
    Argo CK; Loria P; Caldwell SH; Lonardo A
    Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population-Based Cohort Study.
    Garcia-Gil M; Comas-Cufí M; Blanch J; Martí R; Ponjoan A; Alves-Cabratosa L; Petersen I; Marrugat J; Elosua R; Grau M; Ramos R
    Clin Pharmacol Ther; 2018 Oct; 104(4):719-732. PubMed ID: 29194590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alirocumab as add-on therapy to statins: current evidence and clinical potential.
    Auer J; Berent R
    Ther Adv Cardiovasc Dis; 2018 Jul; 12(7):191-202. PubMed ID: 29792380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side Effects.
    Peto R; Collins R
    Circulation; 2018 Oct; 138(15):1499-1501. PubMed ID: 30354509
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis.
    Athyros VG; Katsiki N; Doumas M
    Curr Vasc Pharmacol; 2018 Jan; 16(2):104-106. PubMed ID: 29210655
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid targets during statin treatment in dyslipidemic patients affected by nonalcoholic fatty liver disease.
    Maroni L; Guasti L; Castiglioni L; Marino F; Contini S; Macchi V; De Leo A; Gaudio G; Tozzi M; Grandi AM; Cosentino M; Venco A
    Am J Med Sci; 2011 Nov; 342(5):383-7. PubMed ID: 21629037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
    Calderon RM; Cubeddu LX; Goldberg RB; Schiff ER
    Mayo Clin Proc; 2010 Apr; 85(4):349-56. PubMed ID: 20360293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming Challenges With Statin Therapy.
    Spence JD; Dresser GK
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical controversies in lipid management.
    Tziomalos K
    Panminerva Med; 2015 Jun; 57(2):65-70. PubMed ID: 25669164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of statins in patients with peripheral artery disease.
    Corrado E; Mignano A; Coppola G
    Trends Cardiovasc Med; 2020 Jul; 30(5):257-262. PubMed ID: 31307839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitavastatin and HDL: Effects on plasma levels and function(s).
    Pirillo A; Catapano AL
    Atheroscler Suppl; 2017 Jul; 27():e1-e9. PubMed ID: 28716185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible effect of statins on serum vitamin D levels in patients with chronic renal disease.
    Mazhar F
    Saudi J Kidney Dis Transpl; 2017; 28(2):428-429. PubMed ID: 28352033
    [No Abstract]   [Full Text] [Related]  

  • 39. [Statins and the risk of diabetes].
    Simonyi G
    Orv Hetil; 2013 Oct; 154(43):1691-5. PubMed ID: 24140507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins: Pharmacokinetics, Pharmacodynamics and Cost-Effectiveness Analysis.
    Ricci G; Ciccone MM; Giordano P; Cortese F
    Curr Vasc Pharmacol; 2019; 17(3):213-221. PubMed ID: 29984667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.